Finally, PDGFRB-targeted diagnostic and therapeutic approaches are likely to be valuable in additional tumour types such gastrointestinal stromal tumours (GIST) and stroma-rich carcinomas such as pancreatic cancer. The gene discussed is PDGFRB; the disease is neoplasm.